Oroxylin A, but not vasopressin, ameliorates cardiac dysfunction of endotoxemic rats

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Liu, Chin Hung ^a   Chen, Mei Fang ^a,b   Tseng, Tzu Ling ^a   Chen, Lih Geeng ^c   Kuo, Jon Son ^a   Lee, Tony Jer Fu ^a,d  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^d SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OROXYLIN A; SAPONIN; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG ISOLATION; ENDOTHELIUM LESION; ENDOTOXEMIA; HEART ATRIUM CONTRACTION; HEART FAILURE; HEART FUNCTION TEST; HEART VENTRICLE CONTRACTION; HYPOTENSION; INOTROPISM; ISOLATED HEART; MALE; MUSCLE STRENGTH; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS;

EID: 84870155987     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/408187     Document Type: Article

References (49)

1. Bone R. C., Gram-positive organisms and sepsis. Archives of Internal Medicine 1994 154 1 26 34 2-s2.0-0028040319 10.1001/archinte.154.1.26 (Pubitemid 24018098)
2. Fernandes C. J. Jr., Akamine N., Knobel E., Myocardial depression in sepsis. Shock 2008 30 supplement 1 14 17 2-s2.0-54049158885 10.1097/SHK. 0b013e3181818617
3. Lin H., Wei R. Q., Bolling S. F., Lipopolysaccharide pretreatment of cyclosporine-treated rats enhances cardiac allograft survival. Journal of Surgical Research 1993 55 4 441 445 2-s2.0-0027372858 10.1006/jsre.1993.1166 (Pubitemid 23346887)
4. van der Poll T., Opal S. M., Host-pathogen interactions in sepsis. The Lancet Infectious Diseases 2008 8 1 32 43 2-s2.0-39149097579 10.1016/S1473-3099(07)70265-7
5. Parrillo J. E., Parker M. M., Natanson C., Suffredini A. F., Danner R. L., Cunnion R. E., Ognibene F. P., Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Annals of Internal Medicine 1990 113 3 227 242 2-s2.0-0025303027 (Pubitemid 20242299)
6. Stein B., Frank P., Schmitz W., Scholz H., Thoenes M., Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. Journal of Molecular and Cellular Cardiology 1996 28 8 1631 1639 2-s2.0-0030217871 10.1006/jmcc.1996.0153 (Pubitemid 26300563)
7. Smahi A., Courtois G., Rabia S. H., Döffinger R., Bodemer C., Munnich A., Casanova J. L., Israë A., The NF- κ B signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Human Molecular Genetics 2002 11 20 2371 2375 2-s2.0-0036771830 (Pubitemid 35174700)
8. Merx M. W., Weber C., Sepsis and the heart. Circulation 2007 116 7 793 802 2-s2.0-34547918870 10.1161/CIRCULATIONAHA.106.678359 (Pubitemid 47255997)
9. Tayarani-Najaran Z., Mousavi S. H., Asili J., Emami S. A., Growth-inhibitory effect of Scutellaria lindbergii in human cancer cell lines. Food and Chemical Toxicology 2010 48 2 599 604 2-s2.0-74649084467 10.1016/j.fct.2009.11.038
10. Jiwajinda S., Santisopasri V., Murakami A., Suppressive effects of edible thai plants on superoxide and nitric oxide generation. The Asian Pacific Journal of Cancer Prevention 2002 3 3 215 223
11. Chen Y. C., Yang L. L., Lee T. J. F., Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor- κ B activation. Biochemical Pharmacology 2000 59 11 1445 1457 2-s2.0-0034213030 10.1016/S0006-2952(00)00255-0 (Pubitemid 30177363)
12. Leone M., Albanèse J., Delmas A., Chaabane W., Garnier F., Martin C., Terlipressin in catecholamine-resistant septic shock patients. Shock 2004 22 4 314 319 2-s2.0-7944224614 10.1097/01.shk.0000136097.42048.bd (Pubitemid 39468969)
13. Medel J., Boccara G., Van de Steen E., Bertrand M., Godet G., Coriat P., Terlipressin for treating intraoperative hypotension: can it unmask myocardial ischemia? Anesthesia and Analgesia 2001 93 1 53 55 2-s2.0-0034955593 (Pubitemid 32601152)
14. Lange M., Ertmer C., Westphal M., Vasopressin vs. terlipressinin the treatmentof cardiovascular failure in sepsis. Intensive Care Medicine 2008 34 5 821 832 2-s2.0-42449145538 10.1007/s00134-007-0946-y (Pubitemid 351571184)
15. Müller S., How O. J., Hermansen S. E., Stenberg T. A., Sager G., Myrmel T., Vasopressin impairs brain, heart and kidney perfusion: an experimental study in pigs after transient myocardial ischemia. Critical Care 2008 12 1, article R20 2-s2.0-41049104011 10.1186/cc6794 (Pubitemid 351420398)
16. Dünser M. W., Hasibeder W. R., Vasopressin in vasodilatory shock: ensure organ blood flow, but take care of the heart! Critical Care 2006 10 6, article 172 2-s2.0-34347378090 10.1186/cc5089 (Pubitemid 47087038)
17. Indrambarya T., Boyd J. H., Wang Y., McConechy M., Walley K. R., Low-dose vasopressin infusion results in increased mortality and cardiac dysfunction following ischemia-reperfusion injury in mice. Critical Care 2009 13 3, article R98 2-s2.0-67650689619 10.1186/cc7930
18. Shih H. C., Hsu C. S., Yang L. L., In vitro study of the tocolytic effect of oroxylin A from Scutellaria baicalensis root. Journal of Biomedical Science 2009 16 1, article 27 2-s2.0-65949116782 10.1186/1423-0127-16-27
19. Comini L., Boraso A., Bachetti T., Bernocchi P., Pasini E., Bastianon D., Curello S., Terracciano C. M., Ceconi C., Ferrari R., Effects of endotoxic shock on neuronal NOS and calcium transients in rat cardiac myocytes. Pharmacological Research 2005 51 5 409 417 2-s2.0-20044361987 10.1016/j.phrs.2004.11.001 (Pubitemid 40326192)
20. Klein S. L., Israel J. E., Kronengold R. T., New burst test method for comparing strengths of blood vessel repairs. Microsurgery 1995 16 2 118 121 2-s2.0-0028926027 10.1002/micr.1920160215
21. Graf B. M., Fischer B., Martin E., Bosnjak Z. J., Stowe D. F., Differential effects of arginine vasopressin on isolated guinea pig heart function during perfusion at constant flow and constant pressure. Journal of Cardiovascular Pharmacology 1997 29 1 1 7 2-s2.0-0031012473 10.1097/00005344- 199701000-00001 (Pubitemid 27045167)
22. Boyle W. A. III, Segel L. D., Direct cardiac effects of vasopressin and their reversal by a vascular antagonist. American Journal of Physiology 1986 251 4, part 2 H734 H741 2-s2.0-0022979657
23. Dellinger R. P., Carlet J. M., Masur H., Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Critical Care Medicine 2004 32 3 858 873 2-s2.0-5644220075 (Pubitemid 38344143)
24. Meng X., Ao L., Brown J. M., Fullerton D. A., Banerjee A., Harken A. H., Nitric oxide synthase is not involved in cardiac contractile dysfunction in a rat model of endotoxemia without shock. Shock 1997 7 2 111 118 2-s2.0-0031066709 (Pubitemid 127654257)
25. 15O]water: effect in occasional and chronic users. Journal of Clinical Pharmacology 2004 44 7 751 766 2-s2.0-2942696581 10.1177/0091270004265699 (Pubitemid 38765937)
26. Stowe D. F., Graf B. M., Fujita S., Gross G. J., One-day cold perfusion of bimakalim and butanedione monoxime restores ex situ cardiac function. American Journal of Physiology 1996 271 5, part 2 H1884 H1892 2-s2.0-0029853987
27. McLean P. G., Aston D., Sarkar D., Ahluwalia A., Protease-activated receptor-2 activation causes EDHF-like coronary vasodilation: selective preservation in ischemia/reperfusion injury: involvement of lipoxygenase products, VR1 receptors, and C-fibers. Circulation Research 2002 90 4 465 472 2-s2.0-0037040862 10.1161/hh0402.105372 (Pubitemid 34633917)
28. Ellwood A. J., Curtis M. J., Mechanism of 5-hydroxytryptamine-induced coronary vasodilatation assessed by direct detection of nitric oxide production in guinea-pig isolated heart. British Journal of Pharmacology 1996 119 4 721 729 2-s2.0-0029957525 (Pubitemid 26356585)
29. Barker L. A., Winbery S. L., Smith L. W., McDonough K. H., Supersensitivity and changes in the active population of beta adrenoceptors in rat right atria in early sepsis. Journal of Pharmacology and Experimental Therapeutics 1990 252 2 675 682 2-s2.0-0025308157 (Pubitemid 20101883)
30. Gonzalez-Muñoz C., Nieto-Cerón S., Cabezas-Herrera J., Hernández-Cascales J., Glucagon increases contractility in ventricle but not in atrium of the rat heart. European Journal of Pharmacology 2008 587 1-3 243 247 2-s2.0-44149123542 10.1016/j.ejphar.2008.04.001
31. Vandecasteele G., Eschenhagen T., Scholz H., Stein B., Verde I., Fischmeister R., Muscarinic and β -adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase. Nature Medicine 1999 5 3 331 334 2-s2.0-0033017176 10.1038/6553 (Pubitemid 29124371)
32. Markel T. A., Crisostomo P. R., Wang M., Herrmann J. L., Abarbanell A. M., Meldrum D. R., Right ventricular TNF resistance during endotoxemia: the differential effects on ventricular function. American Journal of Physiology 2007 293 5 R1893 R1897 2-s2.0-36048938940 10.1152/ajpregu.00359.2007 (Pubitemid 350085655)
33. Bogle R. G., McLean P. G., Ahluwalia A., Vallance P., Impaired vascular sensitivity to nitric oxide in the coronary microvasculature after endotoxaemia. British Journal of Pharmacology 2000 130 1 118 124 2-s2.0-0034116007 (Pubitemid 30248434)
34. Neethling W. M. L., Hodge A. J., The effect of diazepam on myocardial function and coronary vascular tone after endotoxemia in the isolated rat heart model. Inflammation Research 2010 59 11 907 913 2-s2.0-78651319203 10.1007/s00011-010-0239-8
35. Du J., An J., Wei N., Guan T., Pritchard K. A., Shi Y., Increased resistance to lps-induced myocardial dysfunction in the brown norway rats versus dahl S rats: roles of inflammatory cytokines and nuclear factor κ b pathway. Shock 2010 33 3 332 336 2-s2.0-77149177056 10.1097/SHK.0b013e3181b7819e
36. Neethling W. M. L., Hodge A. J., The effect of diazepam on myocardial function and coronary vascular tone after endotoxemia in the isolated rat heart model. Inflammation Research 2010 59 11 907 913 2-s2.0-78651319203 10.1007/s00011-010-0239-8
37. Hohlfeld T., Klemm P., Thiemermann C., Warner T. D., Schror K., Vane J. R., The contribution of tumour necrosis factor- α and endothelin-1 to the increase of coronary resistance in hearts from rats treated with endotoxin. British Journal of Pharmacology 1995 116 8 3309 3315 2-s2.0-0029588432 (Pubitemid 26007777)
38. Lee Y. M., Cheng P. Y., Chim L. S., Kung C. W., Ka S. M., Chung M. T., Sheu J. R., Baicalein, an active component of Scutellaria baicalensis Georgi, improves cardiac contractile function in endotoxaemic rats via induction of heme oxygenase-1 and suppression of inflammatory responses. Journal of Ethnopharmacology 2011 135 1 179 185 2-s2.0-79955484515 10.1016/j.jep.2011.03. 009
39. Gregg D. E., Effect of coronary perfusion pressure or coronary flow on oxygen usage of the myocardium. Circulation Research 1963 13 497 500 2-s2.0-0001375335
40. Arnold G., Kosche F., Miessner E., Neitzert A., Lochner W., The importance of the perfusion pressure in the coronary arteries for the contractility and the oxygen consumption of the heart. Pflugers Archiv fur Die Gesamte Physiologie des Menschen und der Tiere 1968 299 4 339 356 2-s2.0-0014375774 10.1007/BF00602910
41. Piepot H. A., Groeneveld A. B. J., van Lambalgen A. A., Sipkema P., Endotoxin impairs endothelium-dependent vasodilation more in the coronary and renal arteries than in other arteries of the rat. Journal of Surgical Research 2003 110 2 413 418 2-s2.0-0037533726 10.1016/S0022-4804(02)00043-4 (Pubitemid 36683040)
42. Lu Z., Lu N., Li C., Oroxylin a inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the erk1/2 signaling pathway. Toxicology Letters 2012 209 3 211 220
43. Geraldes P., King G. L., Activation of protein kinase C isoforms and its impact on diabetic complications. Circulation Research 2010 106 8 1319 1331 2-s2.0-77952468064 10.1161/CIRCRESAHA.110.217117
44. Holmes C. L., Patel B. M., Russell J. A., Walley K. R., Physiology of vasopressin relevant to management of septic shock. Chest 2001 120 3 989 1002 2-s2.0-0034820482 10.1378/chest.120.3.989 (Pubitemid 32885477)
45. Brueggemann L. I., Moran C. J., Barakat J. A., Yeh J. Z., Cribbs L. L., Byron K. L., Vasopressin stimulates action potential firing by protein kinase C-dependent inhibition of KCNQ5 in A7r5 rat aortic smooth muscle cells. American Journal of Physiology 2007 292 3 H1352 H1363 2-s2.0-33847745043 10.1152/ajpheart.00065.2006 (Pubitemid 46377123)
46. Godlewski G., Schlicker E., Baranowska U., Malinowska B., Recruitment of functionally active heart β 2-adrenoceptors in the initial phase of endotoxic shock in pithed rats. Shock 2006 26 5 510 515 2-s2.0-33750379497 10.1097/01.shk.0000228794.95302.c3 (Pubitemid 44632282)
47. Smith L. W., Winbery S. L., Barker L. A., McDonough K. H., Cardiac function and chronotropic sensitivity to β -adrenergic stimulation in sepsis. American Journal of Physiology 1986 251 2, part 2 H405 H412 2-s2.0-0022510747
48. Rittirsch D., Hoesel L. M., Ward P. A., The disconnect between animal models of sepsis and human sepsis. Journal of Leukocyte Biology 2007 81 1 137 143 2-s2.0-33845905763 10.1189/jlb.0806542 (Pubitemid 46021262)
49. Abraham R. G., Mersereau W. A., Chiu R. C., A simplified alloperfused rat heart model for studying myocardial protection. Journal of Investigative Surgery 1988 1 2 107 116 2-s2.0-0024185078